NCT03291561 is a NA clinical trial of Electroacupuncture in Acupuncture, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

Who is sponsoring NCT03291561?

NCT03291561 is sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

What drugs are being tested in NCT03291561?

Interventions in NCT03291561: Electroacupuncture, Sham electroacupuncture.

What condition does NCT03291561 study?

NCT03291561 studies Acupuncture, Gastrointestinal Function.

Is NCT03291561 still recruiting?

NCT03291561 is currently status unknown. Last updated 25 September 2017.

Last reviewed 2017-09-25 · How we verify

NCT03291561

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Perioperative Electroacupuncture After Operation

Status unknown NA Last updated 25 September 2017

What this trial tests

NA trial testing Electroacupuncture in Acupuncture in 400 participants. Status unknown.

Timeline

1 August 2017

Primary endpoint
1 January 2020

31 December 2020

Quick facts

Lead sponsor	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	400
Start date	1 August 2017
Primary completion	1 January 2020
Estimated completion	31 December 2020
Sites	1 location across China

Drugs / interventions tested

Electroacupuncture
Sham electroacupuncture

Conditions studied

Acupuncture — all drugs for Acupuncture →
Gastrointestinal Function — all drugs for Gastrointestinal Function →

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Who can join

Adults 18 to 75, any sex, with Acupuncture or Gastrointestinal Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the effect of perioperative electroacupuncture on rapid rehabilitation for the pancreatic cancer and periampullary carcinoma patients after operation .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Electroacupuncture

Trials testing the same drug.

NCT07530042 — Efficacy of Electroacupuncture Combined With Auricular Acupressure for Chronic Low Back Pain. · NA · not yet recruiting
NCT07509294 — Effect Of Electroacupuncture With Local Anesthesia On Pain And Stress During Impacted Lower Third Molar Surgery · NA · not yet recruiting
NCT07515027 — Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung · NA · recruiting
NCT07487532 — Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation · NA · not yet recruiting
NCT07489625 — Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain · EARLY_PHASE1 · not yet recruiting

Other recruiting trials for Acupuncture

Currently open trials in the same condition.

NCT06910540 — ACU-TENS on Pain and Stress Reduction Before and During TUGOR · NA · recruiting
NCT06725550 — Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 · NA · recruiting
NCT07036393 — Acupuncture Versus Transcutaneous Electrical Nerve Stimulation on Pain Post Upper Abdominal Surgeries · NA · recruiting
NCT07058259 — Acupuncture for Persistent Dyspnea Despite Medical Treatment in COPD · NA · active not recruiting
NCT06757023 — A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment · recruiting

Other Cancer Institute and Hospital, Chinese Academy of Medical Sciences trials

Trials by the same sponsor.

NCT07531563 — Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy · NA · not yet recruiting
NCT07537049 — BR101 in Patients With Relapsed/Refractory Multiple Myeloma · Phase 1 · not yet recruiting
NCT07187154 — The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy · NA · not yet recruiting
NCT07530549 — A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Che · Phase 2 · not yet recruiting
NCT07507058 — Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03291561 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Last refreshed: 25 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03291561.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing